pharma topic page on Anadi Algo News

Sunday, March 15, 2026
DISCLAIMER: AI-generated signals are for informational purposes only. All trading and investment decisions are solely the user's responsibility.|Past performance does not guarantee future results. Trade at your own risk.|Anadi Algo is not a SEBI-registered advisor. Consult a qualified financial advisor before acting on any recommendation.|DISCLAIMER: AI-generated signals are for informational purposes only. All trading and investment decisions are solely the user's responsibility.|Past performance does not guarantee future results. Trade at your own risk.|Anadi Algo is not a SEBI-registered advisor. Consult a qualified financial advisor before acting on any recommendation.|
AnadiAlgoNews
सट्टा नहीं, सिस्टम
Topic Landing|85 matching stories

pharma News, Sentiment & Trading Insights

AI-analyzed coverage for the pharma theme, including latest market stories, signals and related articles.

Top Story|et_companiesabout 12 hours ago

Kathua to become India’s antibiotic powerhouse with Rs 600 crore pharma facility

The Indian pharma sector is actively working to reduce its reliance on imported APIs, especially from China. This investment aligns with the government's 'Make in India' push and Production Linked Incentive (PLI) schemes for pharmaceuticals.

buy
Bullish+6590%
PharmaceuticalsChemicals
+65

Impact Score

Affected Stocks

AUROPHARMAAurobindo Pharma Ltd.
Positive
DIVISLABDivi's Laboratories Ltd.
Positive
GRANULESGranules India Ltd.
Positive
LUPINLupin Ltd.
Positive
Look for opportunities in API-focused pharma companies, as this development signals continued government support and potential for domestic growth, with a bias towards long positions.
et_marketsabout 18 hours ago

F&O Talk | Nifty breaches crucial Fibonacci retracement level; Sudeep Shah on Adani Total and 5 top weekly movers

Banking stocks are under significant pressure due to inflation fears stemming from geopolitical tensions, leading to a sharp selloff in Nifty Bank. This environment emphasizes the importance of asset quality and deposit pricing for bank performance.

sell
Bearish-8095%
5 facts
Bearish bias for banking stocks; consider short positions or avoiding fresh long entries until geopolitical tensions ease and market sentiment improves.
et_marketsabout 20 hours ago

Smallcaps cheaper but not cheap yet: Sonam Srivastava urges selective investing

The banking sector has recently seen significant declines due to inflation fears and crude-driven sell-offs, making the 'private banks' recommendation noteworthy amidst broader market volatility. Investors should assess if the recent correction has made private banks attractive.

Neutral+4090%
5 facts
For private banks, look for strong fundamentals (NIM, asset quality, credit growth) and consider accumulation on dips, but maintain strict stop-losses given the current market sentiment.
et_marketsabout 20 hours ago

Bitcoin nears zone where past bear markets have bottomed out

This news is not directly related to the pharma sector. However, broader market sentiment, influenced by global asset classes like crypto, can indirectly affect all sectors.

Neutral+1060%
5 facts
For pharma, focus remains on regulatory approvals and product pipelines, independent of crypto market movements.

Latest pharma Topic Coverage

et_economy1 day ago-70

US opens trade probe into India, EU, China and others over forced labour policies

5 factsTextilesApparel
Maintain a cautious stance on the broader market, especially on export-oriented stocks, with a bearish bias until more details on the probe's implications are available.
et_economy1 day ago+75

India, UK trade pact may come into effect in one month from now: Piyush Goyal

buy4 factsExportsAutomobiles
N/A for telecom sector in this specific news. Focus remains on ARPU, subscriber growth, and tariff trends for telecom stocks.
livemint_markets1 day ago-75

Rupee hits fresh low on crude surge; RBI likely intervenes

5 factsOil & GasInformation Technology
Monitor Nifty Bank for further downside if inflation concerns escalate; consider short-term hedges or reducing exposure to rate-sensitive banking stocks.
livemint_companies1 day ago+10

Top FDA drug official is trying to hire a friend whos seeking a bold new warning on antidepressants

5 factspharma
No immediate trade setup for Indian stocks; watch for specific drug names or companies mentioned in future updates.
et_companies1 day ago+50

Hospitality industry bodies welcome govt decision to allocate 20% of average monthly commercial LPG requirement to hotels, restaurants

buy5 factsINDIANHOTSECLERXCHALETpharma
Consider a bullish bias for hospitality sector stocks, especially those with significant F&B operations.
livemint_markets1 day ago-60

Innovision IPO sees tepid response on Day 4; subscribed 0.31 times, GMP signals flat listing

sell5 factspharma
Bearish for new listings, especially those with weak initial subscription.
et_companies1 day ago+75

Tata Motors bags orders for over 5000 buses and chassis

buy5 factsTATAMOTORSpharma
Consider a bullish bias for Tata Motors, particularly in its commercial vehicle division, given the strong order book.
et_markets1 day ago-85

Rupee hits record low as oil risks, offshore dollar bids mount

sell5 factsOil & GasBanking & Financial Services
Short-term bearish bias for sectors with high import dependency; consider defensive plays or export-oriented stocks, but be mindful of overall market sentiment.
et_markets1 day ago-70

Jefferies adds Wipro, Hyundai Motor India, Cipla to latest underperform list. Here’s why

sell5 factsWIPROCIPLAInformation TechnologyAutomobiles
For auto stocks, maintain a bearish bias, especially for those facing specific company-level challenges like Hyundai. Look for shorting opportunities or avoid fresh long positions, with strict stop-losses.
livemint_markets2 days ago+59.4

Global markets entering change of eras, but India ticking boxes for FII return: Mirae's Swarup Mohanty

5 factspharma
Maintain a bullish bias on the broader Indian market, particularly in sectors with strong earnings visibility.|Quick check: SUNPHARMA bullish bias (overbought), CIPLA bearish bias (-0.5% 1d).
livemint_markets2 days ago-60.3

SBI share price hits four-week low as selling intensifies; m-cap slips below ₹10 lakh crore

hold5 factsAXISBANKBankingFinancial Services
Maintain a bearish bias on banking stocks, especially public sector banks, looking for shorting opportunities on any technical bounces. Use stop-losses diligently.|Quick check: AXISBANK bearish bias (oversold), SUNPHARMA bullish bias (overbought).
et_markets2 days ago+38.5

2 top stock picks from CA Rudramurthy BV for near term

5 factsPharmaceuticalsMetals & Mining
Maintain a bearish bias on banking stocks; consider short positions or reducing exposure, with strict stop-losses given the recent sharp declines.|Quick check: NIFTY neutral, HDFCBANK bearish bias (oversold).
livemint_markets2 days ago+63.3

Rajesh Palviya of Axis Sec suggests Linde India, ACME Solar, Ajanta Pharma shares to buy today

buy5 factsLINDEINDIAAJANTPHARMChemicalsRenewable Energy
For pharma, look for companies with strong product pipelines and stable regulatory environments; for industrials/renewables, assess growth prospects independent of short-term market swings. Maintain a bullish bias on these specific recommendations but with tight risk management.|Quick check: LINDEINDIA bullish bias (+7.1% 1d), AJANTPHARM bullish bias (+2.0% 1d).
et_markets2 days ago-72.8

Rupee hits record intra-day low in early trade, falls 12 paise to 92.37 against US dollar

sell5 factsOil & GasInformation Technology
Maintain a cautious stance on import-dependent sectors; consider long positions in strong export-oriented companies with good hedging strategies.|Quick check: MARUTI bearish bias (oversold), TATASTEEL bearish bias (-0.6% 1d).
livemint_markets2 days ago+25.6

Innovision IPO Day 4: Issue booked 30% so far, price band cut to ₹494-519 apiece. GMP trades flat. Apply or not?

5 factspharma
For IPOs with flat GMP, short-term listing gain opportunities are limited. Focus on the company's fundamentals for long-term investment decisions.|Quick check: SUNPHARMA bullish bias (overbought), CIPLA bearish bias (-0.5% 1d).
et_companies2 days ago+48.1

India’s Rs 13,000 crore live events market fuelling experiential marketing push: BookMyShow–EY report

hold5 factsEntertainmentMedia
Look for Indian entertainment and event management stocks with strong balance sheets and growth potential; consider a long bias with a focus on companies leveraging this experiential shift.|Quick check: SUNPHARMA bullish bias (overbought), CIPLA bearish bias (-0.5% 1d).
et_companies3 days ago+25.6

How Today Group is shaping the next chapter of Navi Mumbai

5 factspharma
Bullish for real estate developers with strong projects in developing urban centers.|Quick check: SUNPHARMA bullish bias (overbought), CIPLA bearish bias (-0.5% 1d).
et_markets3 days ago+72.8

Coal India among 4 stocks that hit 52-week highs & rallied up to 15% in a month

buy5 factsCOALINDIAAUROPHARMAABBMiningPharmaceuticals
For pharma, look for companies with strong product pipelines and favorable regulatory signals for potential long-term growth. For power, consider short-term momentum plays given the recent index surge, but be mindful of potential profit-booking.|Quick check: COALINDIA bullish bias (overbought), AUROPHARMA bullish bias (overbought).
et_economy3 days ago+33.1

India begins probe into circumvention of countervailing duty on saccharin imports

5 factspharma
Identify Indian companies that produce saccharin or its substitutes, as they could benefit from reduced competition. Companies heavily reliant on imported saccharin might face increased costs.|Quick check: SUNPHARMA bullish bias (overbought), CIPLA bearish bias (-0.5% 1d).
et_markets3 days ago-54.3

Rupee recovers from record lows, settles 16 paise down at 92.17 against US dollar

5 factsOil & GasIT Services
Monitor crude oil price movements and FII flow data; consider long positions in export-heavy IT and pharma stocks, and short positions or hedges in sectors with high import dependency.|Quick check: TATASTEEL bearish bias (-0.6% 1d), HINDALCO bullish bias (+1.1% 1d).
livemint_markets3 days ago-53.2

Top Gainers & Losers on Mar 12: Piramal Pharma, Tejas Networks, Apollo Tyres, PG Electroplast among top losers

hold5 factsPIRAMALPHTEJASNETAPOLLOTYREAutomobilesPharmaceuticals
Maintain a defensive stance; consider short-term hedges or reducing exposure in cyclical sectors like auto until geopolitical stability improves.|Quick check: PIRAMALPH neutral, TEJASNET neutral (-4.7% 1d).
livemint_markets3 days ago+8.2

Ambuja’s shift from volume chase to value accretion may take time to pay off

sell5 factsAMBUJACEMpharma
Neutral bias for Ambuja Cements in the short term; long-term positive if the strategy proves successful. Watch for execution and market acceptance of premium products.|Quick check: AMBUJACEM bearish bias (oversold), SUNPHARMA bullish bias (overbought).
livemint_markets3 days ago+27.2

Stocks to buy or sell: Osho Krishan of Angel One suggests buying Wipro, Dr Reddys shares to buy in the near-term

hold5 factsWIPROInformation TechnologyPharmaceuticals
Look for entry points in recommended IT and Pharma stocks, using technical levels for risk management, as these sectors may offer resilience amidst market corrections.|Quick check: WIPRO neutral (+0.5% 1d), NIFTY neutral.
et_companies3 days ago+60.2

Mukesh Ambani's Reliance capitalises on shifting energy alliances with US refinery pledge

hold5 factsRELIANCEOil & GasRefining & Marketing
Look for increased capital expenditure announcements or definitive agreements from Reliance in the refining sector, indicating further upside potential.|Quick check: RELIANCE bearish bias (-1.6% 1d), SUNPHARMA bullish bias (overbought).
et_companies3 days ago+20.6

KT Professional launches KT Men, partners MI and RCB to tap India’s men’s grooming market

5 factsConsumer GoodsPersonal Care
Consider long-term investments in established consumer goods companies with strong brand recognition and distribution networks in the personal care segment, but be mindful of increasing competition.|Quick check: SUNPHARMA bullish bias (overbought), CIPLA neutral (-0.3% 1d).
et_markets3 days ago+13.8

Bitcoin consolidates near $70,000 as macro uncertainty offsets institutional demand

5 facts
Monitor FII/DII activity for shifts in sentiment; consider defensive sectors like pharma for stability if global macro uncertainty persists.|Quick check: SUNPHARMA bullish bias (overbought), CIPLA neutral (-0.3% 1d).
et_markets3 days ago+50

Stock to buy: Jefferies lists 10 reasons to buy its top CRDMO pick Sai Life Sciences

hold5 factsPharmaceuticalsContract Research and Manufacturing Services (CRDMO)
Look for accumulation in Sai Life Sciences, potentially on dips, with a bullish bias given the strong analyst endorsement.|Quick check: NIFTY neutral, BANKNIFTY neutral.
et_companies3 days ago-50.7

Iran war exposes cracks for airlines that connect the world

5 factsAviation
Maintain a bearish bias on aviation stocks, particularly those with significant international operations, looking for shorting opportunities or reducing long positions.|Quick check: SUNPHARMA bullish bias (overbought), CIPLA neutral (-0.3% 1d).
et_markets3 days ago+48.8

Spooked by Iran war? 7 stocks that are predicted to double investor wealth over next 12 months

hold5 factsALLCARGOTARSONSUGROCAPpharma
Investors should conduct due diligence on these specific stocks for long-term investment, focusing on their fundamentals and growth drivers.|Quick check: ALLCARGO neutral, TARSONS neutral.
et_markets3 days ago+13.6

Global Market | Chinese exporters rush to hedge currency risks as Yuan strengthens

5 factsexportforex
For Indian companies with significant trade exposure to China, monitor their hedging strategies and currency risk disclosures. No direct pharma sector impact is evident.|Quick check: NIFTY neutral, SENSEX neutral.
et_markets3 days ago-68.9

Rs 5 lakh crore wiped out in minutes as Sensex plunges 1,000 points; Nifty below 23,600. 5 reasons behind today’s market crash

hold5 factsOil & GasFinancials
For pharma, look for companies with strong domestic focus and stable product pipelines; consider long-term accumulation on dips rather than aggressive short-term trades.|Quick check: NIFTY neutral, SENSEX neutral.
et_markets3 days ago+61.8

AI euphoria: How India's old economy is giving FIIs a safe hiding place

5 factsMetals & MiningCapital Goods
Monitor pharma stocks for any spillover effect from broader FII rebalancing, but the primary focus for FII inflows is currently elsewhere.|Quick check: SUNPHARMA bullish bias (overbought), CIPLA neutral (-0.3% 1d).
et_markets3 days ago+47.2

Jindal Saw among 3 stocks flashing bullish signals, hinting at a possible uptrend

buy4 factsJINDALSAW
Bullish bias for Jindal Saw based on technical analysis.|Quick check: JINDALSAW bullish bias (+18.5% 1d), SUNPHARMA bullish bias (overbought).
et_companies3 days ago-24.4

India warns drugmakers against direct or surrogate weight-loss drug and obesity ads

buy5 factspharma
Neutral to slightly bearish bias for pharma companies heavily invested in the weight-loss drug segment.|Quick check: SUNPHARMA bullish bias (overbought), CIPLA neutral (-0.3% 1d).
et_economy3 days ago+61.8

Eased FDI norms balance capital inflows and strategic safeguards: Experts

5 factsManufacturingCapital Goods
Look for opportunities in manufacturing and infrastructure stocks that could see increased investment and demand due to enhanced FDI inflows and supply chain integration, with a bullish bias.|Quick check: SUNPHARMA bullish bias (overbought), CIPLA neutral (-0.3% 1d).
et_economy4 days ago+50.6

FDI easing not for Chinese firms; to benefit entities with minority Chinese holding

5 factsManufacturingCapital Goods
Maintain a bullish bias on pharma stocks with strong product pipelines and positive regulatory outcomes, as this FDI news is unlikely to directly impact the sector's core drivers.|Quick check: SUNPHARMA bullish bias (overbought), CIPLA neutral (-0.3% 1d).
et_companies4 days ago-31.9

Govt cautions pharma cos against surrogate ads for promoting GLP-1 drugs

5 factspharma
Negative for pharma companies with aggressive GLP-1 marketing; consider short-term downside risk.|Quick check: SUNPHARMA bullish bias (overbought), CIPLA neutral (-0.3% 1d).
et_markets4 days ago+5.6

Oracle shares rally 12% as strong revenue forecast eases concerns over massive AI bets

4 factspharma
No direct trade setup for Indian markets.|Quick check: SUNPHARMA bullish bias (overbought), CIPLA neutral (-0.3% 1d).
livemint_markets4 days ago+55.4

Indian rupee falls 16 paise to end at 92.01 against US dollar as crude prices rebound

5 factsOil & GasIT Services
Bearish bias for sectors heavily reliant on imported raw materials or crude oil; bullish bias for export-oriented sectors like IT and pharmaceuticals due to better realization in INR terms.|Quick check: TATASTEEL bearish bias (-0.3% 1d), HINDALCO bullish bias (+0.1% 1d).
et_companies4 days ago+50.6

India-made B28 bullet train to debut on Surat–Vapi stretch of Mumbai–Ahmedabad corridor in Aug 2027

5 factspharma
Identify companies in the railway sector, including rolling stock manufacturers, signaling companies, and civil construction firms, that stand to benefit from these projects.|Quick check: SUNPHARMA bullish bias (overbought), CIPLA neutral (-0.3% 1d).
livemint_markets4 days ago+39.5

Top Gainers & Losers on Mar 11: Apar Industries, Redington, Axis Bank, Finolex Cables, TVS Motor among top losers

sell5 factsAPARINDSREDINGTONAXISBANKAutomobileBanking
Bearish bias for banking stocks; consider short positions or reducing exposure, with strict stop-losses if geopolitical tensions ease.|Quick check: APARINDS bearish bias (-7.7% 1d), REDINGTON bearish bias (-4.0% 1d).
et_economy4 days ago+61.8

India to ease curbs, fast-track Chinese investment in more sectors

5 factselectronicscapital goods
Monitor companies in electronics, capital goods, and solar for potential joint ventures or increased production capacity announcements.|Quick check: SUNPHARMA bullish bias (overbought), CIPLA neutral (-0.3% 1d).
et_economy4 days ago+59.6

India will stem the flood of Chinese imports with China's own money

5 factsManufacturingCapital Goods
Look for opportunities in manufacturing and industrial stocks, particularly those involved in components and intermediate goods, with a long-term bullish bias.|Quick check: SUNPHARMA bullish bias (overbought), CIPLA neutral (+0.8% 1d).
et_markets4 days ago+58.1

Power sector remains a safe bet for investors amid volatility: Gautam Trivedi

5 factsPowerInformation Technology
Look for established power generation, transmission, and distribution companies with strong fundamentals; consider a long bias with a focus on dividend-yielding stocks.|Quick check: SUNPHARMA bullish bias (overbought), CIPLA neutral (+0.8% 1d).
livemint_markets4 days ago+60.9

Small-cap stock HG Infra surges 20% despite stock market crash on order win. Details here

buy5 factsHGINFRAInfrastructureConstruction
Look for continued upward momentum in HG Infra, potentially targeting resistance levels, while setting tight stop-losses due to the inherent risk in small-cap stocks.|Quick check: HGINFRA neutral, SUNPHARMA bullish bias (overbought).
livemint_companies4 days ago+64.6

Adani Energy Solutions raises $500 million from Apollo Global through dollar bonds

buy5 factsADANIENSOLUtilitiesInfrastructure
Look for sustained upward momentum in ADANIENSOL, potentially driven by renewed investor confidence in the Adani Group's financial management.|Quick check: ADANIENSOL bullish bias (+4.2% 1d), SUNPHARMA bullish bias (overbought).
livemint_markets4 days ago+59.6

SEDEMAC Mechatronics share price extends gains after strong listing. Should you buy, sell or hold the stock?

buy5 factspharma
Bullish bias for SEDEMAC Mechatronics in the near term, but watch for consolidation or profit booking after the initial surge.|Quick check: SUNPHARMA bullish bias (overbought), CIPLA neutral (+0.8% 1d).
et_markets4 days ago+37.1

Markets stay in a downtrend; sugar and pharma offer pockets of resilience: Rohit Srivastava

5 factsPharmaceuticalsSugar
Look for pharmaceutical and sugar stocks with strong balance sheets and consistent earnings, with a long-term accumulation bias.|Quick check: SUNPHARMA bullish bias (overbought), CIPLA neutral (+0.8% 1d).
et_markets4 days ago+14.6

Bitcoin nears $70K as easing geopolitical tensions, weaker dollar lift sentiment

5 facts
Focus on company-specific news like USFDA approvals or new drug launches for pharma stocks, rather than broader crypto trends.|Quick check: SUNPHARMA bullish bias (overbought), CIPLA neutral (+0.8% 1d).
et_markets4 days ago+37.1

Bitcoin nears $70K as easing geopolitical tensions, weaker dollar lift sentiment

5 facts
Monitor global risk indicators and FII flow data; a sustained positive trend in global sentiment could provide tailwinds for Indian equities, particularly large-cap indices.|Quick check: SUNPHARMA bullish bias (overbought), CIPLA neutral (+0.8% 1d).
et_markets4 days ago+22.8

Cupid shares plunge 6% after 15% rally over two days: What lies ahead?

hold5 factsCUPIDPharmaceuticals
Given the current market volatility, traders should prioritize risk management and consider short-term trades with tight stop-losses, especially in stocks reacting to corporate actions.|Quick check: CUPID neutral, NIFTY neutral.
et_markets4 days ago+43.9

Private banks, tech and capex stocks look promising after market dip: Sandip Agarwal

5 factsBankingInformation Technology
Look for private banks with robust balance sheets and consistent credit growth; consider long positions with a stop-loss below recent support levels.|Quick check: HDFCBANK bearish bias (oversold), ICICIBANK bearish bias (oversold).
livemint_markets4 days ago+52.1

Why is IndiGo share price rising 3% despite CEO Pieter Elbers' resignation? Explained

hold5 factsINDIGOAviation
Maintain a bullish bias on aviation stocks, particularly market leaders like IndiGo, looking for entry points during minor corrections, with a stop-loss below key support levels.|Quick check: INDIGO bearish bias (oversold), SUNPHARMA bullish bias (overbought).
et_markets4 days ago+30.2

Sensex opens nearly flat above 78,000, Nifty below 24,250 amid mixed global cues

5 factsMetalPharma
Consider short-term long positions in strong pharma stocks with positive news flow, but be mindful of potential regulatory headwinds.|Quick check: NIFTY neutral, SENSEX neutral.
livemint_markets4 days ago+32.2

Stock market today: Trade setup for Nifty 50, US-Iran war, crude oil, gold, silver rates — 8 stocks to buy or sell

hold5 factsCANFINHOMEEMCUREPHARFinancial ServicesPharmaceuticals
For pharma, look for companies with strong product pipelines and favorable regulatory signals; for financial services, monitor interest rate trends and credit growth.|Quick check: CANFINHOME neutral (+6.0% 1d), EMCUREPHAR neutral.
livemint_markets4 days ago-26.6

IndiGo share price to remain in focus today after CEO Pieter Elbers resigns

hold5 factsINDIGOpharma
Bearish bias for IndiGo in the short term due to leadership uncertainty.|Quick check: INDIGO bearish bias (oversold), SUNPHARMA bullish bias (overbought).
livemint_markets4 days ago+22.5

Breakout stocks to buy or sell: Sumeet Bagadia recommends five shares to buy today — 11 March 2026

hold4 factsANURASSCHNEIDERMMFSLpharma
Bullish for the recommended stocks; consider long positions.|Quick check: ANURAS neutral, SCHNEIDER neutral.
livemint_companies4 days ago+18.7

Ozempic's drug maker, Novo Nordisk, receives FDA warning letter over unreported side effects: What are they?

buy5 factsLUPINDRREDDYpharma
Neutral for Indian pharma; however, any news of increased FDA oversight could create short-term volatility for companies with significant US revenue.|Quick check: LUPIN bullish bias (+2.0% 1d), DRREDDY bullish bias (+2.3% 1d).
et_markets5 days ago+61.1

Investors turn to India as private market outpaces regional peers, McKinsey survey shows

5 factsFinancial ServicesPrivate Equity
Monitor sectors and companies that are major beneficiaries of private equity and venture capital funding for potential long-term investment opportunities.|Quick check: SUNPHARMA bullish bias (overbought), CIPLA neutral (+0.8% 1d).
et_economy5 days ago+61.1

Cabinet clears revised cost of Rs 3,630.77 crore for developing road connectivity to Jewar airport

5 factspharma
Look for companies with a strong presence in road construction and infrastructure development in North India.|Quick check: SUNPHARMA bullish bias (overbought), CIPLA neutral (+0.8% 1d).
et_economy5 days ago+66.5

India's exports of active pharma ingredients at Rs 41,500 cr surpassed imports in FY25

buy5 factsGRANULESpharma
Long-term bullish on Indian API manufacturers, especially those participating in the PLI scheme.|Quick check: GRANULES bullish bias (+4.0% 1d), SUNPHARMA bullish bias (overbought).
et_companies5 days ago+61.1

India's exports of active pharma ingredients at Rs 41,500 cr surpassed imports in FY25

5 factspharma
Positive for domestic API manufacturers; identify companies with strong API production capabilities and PLI scheme beneficiaries.|Quick check: SUNPHARMA bullish bias (overbought), CIPLA neutral (+0.8% 1d).
et_markets5 days ago+56.2

Aditya Birla Sun Life AMC among 5 stocks at 52-week high; rally up to 20% in a month

hold5 factsADITYABIRLAJBCHEMPHARMFinancial ServicesPharmaceuticals
Maintain a bullish bias on the broader market, focusing on stocks demonstrating strong technical breakouts and sustained upward momentum, while being mindful of potential profit-booking after sharp rallies.|Quick check: ADITYABIRLA neutral, JBCHEMPHARM neutral.
livemint_companies5 days ago+38.6

Experimenting with vibe coding? Nithin Kamath says ‘If I traded and had Claude…’

hold4 factspharma
Bullish for fintech companies providing trading tools and APIs; neutral for the broader market, but indicates evolving trading patterns.|Quick check: SUNPHARMA bullish bias (overbought), CIPLA neutral (+0.8% 1d).
et_markets5 days ago+40.9

Pharma and PSU banks emerge as safe havens as markets navigate volatility

hold5 factsPharmaceuticalsBanking
Look for long opportunities in fundamentally strong PSU banks, focusing on those with improving asset quality and stable NIMs, with a stop-loss below recent support levels.|Quick check: NIFTY neutral, HDFCBANK bearish bias (oversold).
et_markets5 days ago+58.7

Happiest Minds shares rocket 12% as firm raises guidance to 12.5% on AI First launch success

buy5 factsHAPPSTMNSpharma
Bullish for Happiest Minds Technologies; positive sentiment may spill over to other mid-cap IT services companies with strong AI capabilities.|Quick check: HAPPSTMNS neutral, SUNPHARMA bullish bias (overbought).
et_markets5 days ago+53.6

India gains favour with global investors on returns, ESG momentum

5 factspharma
Bullish for Indian equities, particularly companies with high ESG scores; monitor for increased FII activity.|Quick check: SUNPHARMA bullish bias (overbought), CIPLA neutral (+0.8% 1d).
livemint_companies5 days ago+36.2

Inside Royal Orchid’s playbook for India’s next hotel boom

buy5 factsROHLTDpharma
Look for Royal Orchid Hotels to potentially outperform peers with its strategic expansion.|Quick check: ROHLTD neutral, SUNPHARMA bullish bias (overbought).
et_markets5 days ago+14.6

Bitcoin rebounds to $70K as easing Middle East tensions and oil price pullback lift crypto sentiment

5 factspharma
Neutral for Indian equities, but a positive indicator for global risk-on sentiment.|Quick check: SUNPHARMA bullish bias (overbought), CIPLA neutral (+0.8% 1d).
et_markets5 days ago+52.1

Three decades of markets: A Balasubramanian on compounding, investor evolution and India’s long-term promise

5 factspharma
Long-term bullish bias for the broader Indian market; focus on diversified portfolios.|Quick check: SUNPHARMA bullish bias (overbought), CIPLA neutral (+0.8% 1d).
livemint_markets5 days ago+33.4

Park Medi World stock price climbs to a new peak after this update

buy5 factspharma
Bullish for well-received IPOs; analyze post-listing performance for momentum plays.|Quick check: SUNPHARMA bullish bias (overbought), CIPLA neutral (+0.8% 1d).
et_markets5 days ago+49.9

Market panic temporary; midcaps and IT offer long-term value: Deepak Shenoy

5 factspharma
Long-term bullish bias for IT and infrastructure; consider staggered investments during dips.|Quick check: NIFTY neutral, SUNPHARMA bullish bias (overbought).
livemint_markets5 days ago+40.9

Upcoming IPO: Warburg Pincus backed Truhome Finance files draft papers for ₹3,000 crore IPO

5 factspharma
Neutral for the overall market; for financial services, watch for successful IPOs as a sentiment booster.|Quick check: SUNPHARMA bullish bias (overbought), CIPLA neutral (+0.8% 1d).
et_markets5 days ago+59.6

‘Downright Panic’: Traders tested to limits on oil’s wild Monday

5 factspharma
Neutral to bearish for oil-importing sectors; avoid aggressive long positions until oil price stability returns.|Quick check: SUNPHARMA bullish bias (overbought), CIPLA neutral (+0.8% 1d).
Equitymaster5 days ago+56.8

Sensex Today Trades Higher | Nifty Above 24,100 | Natco Pharma Up 4% - Equitymaster

buy5 factsNATCOPHARMpharma
Look for Nifty to sustain above 24,100; consider long positions in strong performing stocks like Natco Pharma.|Quick check: NATCOPHARM bullish bias (overbought), NIFTY neutral.
et_markets5 days ago+4.9

US Stock Market | Fed chief reaches out to lawmakers after DOJ probe revelation

3 factspharma
No direct trade setup for Indian markets.|Quick check: SUNPHARMA bullish bias (overbought), CIPLA neutral (+0.8% 1d).
NDTV Profit5 days ago+26.9

Five Stocks To Buy: Infosys, Praj Industries, Sun Pharma, Federal Bank And DMart | March 10, 2026 - NDTV Profit

hold5 factsINFYPRAJINDSUNPHARMAbankingIT
Look for entry points in the mentioned stocks, potentially on dips, with appropriate stop-losses.|Quick check: INFY bearish bias (oversold), PRAJIND neutral (+0.8% 1d).
et_economy6 days ago+57.4

FTAs to provide huge export opportunities for pharma, healthcare sectors: Piyush Goyal

5 factspharmahealthcare
Bullish on the Indian pharma and healthcare sectors, particularly companies with a strong international presence or those actively exploring new export markets.|Quick check: SUNPHARMA bullish bias (overbought), CIPLA neutral (+0.8% 1d).
NDTV Profit6 days ago-7.3

Stock Picks Today: Ambuja Cement, Paytm, Torrent Pharma, Infosys, And More On Brokerages' Radar - NDTV Profit

sell4 factsAMBUJACEMPAYTMTORNTPHARMpharma
No immediate action based on this stale news; assess current analyst consensus and company fundamentals.|Quick check: AMBUJACEM bearish bias (oversold), PAYTM bearish bias (oversold).
NDTV Profit10 days ago+41

Stock Picks Today, March 5: L&T, Coal India, Sun Pharma, India Trucking Cycle And More On Brokerages' Radar - NDTV Profit

buy4 factsCOALINDIASUNPHARMAinfrapharma
Neutral, as this is historical data. Use it to understand past market dynamics and potential long-term themes.|Quick check: COALINDIA bullish bias (+1.2% 1d), SUNPHARMA bullish bias (overbought).
Samco14 days ago+4.9

Top 14 Pharma Stocks To Buy In India March 2026 - Samco

4 factspharma
Neutral on specific recommendations from this article; focus on current pharma sector trends like USFDA approvals, domestic growth, and R&D pipelines.|Quick check: SUNPHARMA bullish bias (overbought), CIPLA neutral (+0.8% 1d).